← The library
FDA-approved

Semaglutide

aka Ozempic, Wegovy, Rybelsus

Mimics the "I'm full" hormone your gut sends after eating. Sold as Ozempic / Wegovy.

Technically · GLP-1 agonist

weight lossfat loss
Ozempic
The vial
Semaglutide 2D molecular structure
The moleculeCID 56843331

In one sentence

The original blockbuster weight-loss shot — slows your stomach, kills the urge to eat between meals.

A weekly appetite brake. Hunger fades, portions shrink, scale moves.

Half-life

~7 days

Stays active about a week — one shot per week (or a daily pill).

Dosing

Once weekly (subQ); daily for oral form

How often you take a dose

Route

SubQ · Oral

How it goes into the body

Status

FDA

Approved by the FDA for prescription use

Education only. Many compounds discussed are research chemicals not approved for human use in the US. This is not medical advice — consult a licensed physician.

What it is

The drug that started the modern weight-loss revolution. It copies a hormone (GLP-1) that your gut already releases when you eat. Approved by the FDA for diabetes (Ozempic), obesity (Wegovy), and as a daily pill (Rybelsus).

The full technical answer

FDA-approved GLP-1 receptor agonist. Ozempic for type 2 diabetes, Wegovy for chronic weight management, Rybelsus for oral T2D.

How it works

After a meal, your gut releases GLP-1 to tell your brain "you're full" and your pancreas "release insulin." Semaglutide is a stronger, longer-lasting version of that same signal. Hunger fades, portions shrink, blood sugar stays stable.

The full technical answer

Activates GLP-1 receptors to suppress appetite, slow gastric emptying, and enhance glucose-dependent insulin secretion.

ExtracellularInside the cellGLP-1Receptorpeptidedownstream signaling
Receptors hit: GLP-1. The peptide binds the receptor on the cell surface, triggering downstream signaling inside the cell.

What the research says

STEP trials showed ~15% weight loss at 68 weeks at 2.4mg/week.

Sources: STEP-1 NEJM · FDA Wegovy label

Common dosing ranges

Range
Start 0.25 mg/week, titrate to 2.4 mg/week
Frequency
Once weekly (subQ); daily for oral form
Duration
Long-term per FDA label

Sources: FDA label

How to take it

Practical guidance synthesized from clinical protocols, FDA labels, and clinician interviews. Always cross-check with a prescribing physician.

Best time of day

SubQ: same day each week, any time. Oral (Rybelsus): first thing in the AM, fasted, with 4 oz of water, then nothing else for 30 minutes.

With food or fasted

SubQ: doesn't matter. Oral: STRICTLY fasted — 30 min before any food, drink, or other medication.

How long to cycle

Long-term. Titrate slowly: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly (typically each step lasts 4 weeks).

When to get off

Severe GI side effects, pancreatitis symptoms (sharp belly pain that radiates to back), or thyroid lumps. Discuss break protocols with doctor — going off cold turkey often leads to rapid regain.

Administration

SubQ
Oral

Side effects

Common

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation

Serious / theoretical

  • Pancreatitis
  • Gallbladder disease
  • Thyroid C-cell tumor warning

Sources: FDA label

Often compared